Atlas FDA

PROGENSA PCA3 ASSAY

FDA premarket approval P100033/S004 · decided 2015-11-12

Approval details

PMA number
P100033
Supplement
S004
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PROGENSA PCA3 ASSAY
Generic name
Prostrate cancer genes nucleic acid amplification test system
Applicant
Gen-Probe Incorporated
Date received
2015-06-10
Decision date
2015-11-12
Days to decision
155 days
Decision code
APPR
Product code
OYM
Advisory committee
Pathology
Expedited review
No
Location
San Diego, CA
Statement
APPROVAL FOR THE INTRODUCTION OF A NEW VIAL FILLER (THE CAPMATIC LINEAR BAMBINO FILLING SYSTEM) AT THE GCD1 MANUFACTURING FACILITY.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
APTIMA TRICHOMONAS VAGINALIS ASSAY (DEN110012)Gen-Probe Incorporated2011-04-19